Official 2024 U.S. DOL Form 5500 summary for Regeneron Pharmaceuticals, INC. (Regeneron Pharmaceuticals, INC. 401(k) Savings Plan · EIN 13-3444607 · PN 001): $2.61B net assets, 11,960 active participants, and $2.25 per $10,000 (2.25 bps).
| Plan Sponsor | Regeneron Pharmaceuticals, INC. |
|---|---|
| Filing Identifier | Regeneron Pharmaceuticals, INC. 401(k) Savings Plan · EIN 13-3444607 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (NY) |
| Asset-Size Peer Cohort | >$1B |
| Plan Net Assets (2024) | $2.61B |
| Active Participants | 11,960 |
| Direct Admin Fee Rate | $2.25 per $10,000 (2.25 bps) |
| Cohort Peer Median | $4.40 per $10,000 (4.40 bps) |
| Primary Recordkeeper / Provider | Fidelity Investments |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI
Verified federal filings reconciled for Regeneron Pharmaceuticals across sibling Meru AI platforms.